CN Patent

CN105616418A — 含有细胞周期蛋白抑制剂的药物制剂及其制备方法

Assigned to Jiangsu Hansoh Pharmaceutical Group Co Ltd · Expires 2016-06-01 · 10y expired

What this patent protects

本发明公开了含有细胞周期蛋白抑制剂的药物制剂及其制备方法。具体地，本发明涉及一种以式Ⅰ所示的6-乙酰基-8-环戊基-5-甲基-2-(5-哌嗪-1-基-吡啶-2-基氨基)-8H-吡啶并[2,3-d]嘧啶-7-酮或其盐为活性成分的药物制剂，所述盐包括盐酸盐、羟乙基磺酸盐，所述药物剂型包括片剂、胶囊剂。所述剂型均具有良好的稳定性以及优异的溶出行为。

USPTO Abstract

本发明公开了含有细胞周期蛋白抑制剂的药物制剂及其制备方法。具体地，本发明涉及一种以式Ⅰ所示的6-乙酰基-8-环戊基-5-甲基-2-(5-哌嗪-1-基-吡啶-2-基氨基)-8H-吡啶并[2,3-d]嘧啶-7-酮或其盐为活性成分的药物制剂，所述盐包括盐酸盐、羟乙基磺酸盐，所述药物剂型包括片剂、胶囊剂。所述剂型均具有良好的稳定性以及优异的溶出行为。

Drugs covered by this patent

Patent Metadata

Patent number
CN105616418A
Jurisdiction
CN
Classification
—
Expires
2016-06-01
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hansoh Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.